1 Market Overview of Cancer Biologics 1.1 Cancer Biologics Market Overview 1.1.1 Cancer Biologics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Cancer Biologics Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Cancer Biologics Market Size by Region (2015-2026) 1.4 Global Cancer Biologics Historic Market Size by Region (2015-2020) 1.5 Global Cancer Biologics Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Cancer Biologics Market Size YoY Growth (2015-2026) 1.6.1 North America Cancer Biologics Market Size YoY Growth (2015-2026) 1.6.2 Europe Cancer Biologics Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Cancer Biologics Market Size YoY Growth (2015-2026) 1.6.4 Latin America Cancer Biologics Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Cancer Biologics Market Size YoY Growth (2015-2026) 2 Cancer Biologics Market Overview by Type 2.1 Global Cancer Biologics Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Cancer Biologics Historic Market Size by Type (2015-2020) 2.3 Global Cancer Biologics Forecasted Market Size by Type (2021-2026) 2.4 Monoclonal Antibodies 2.5 Vaccines 2.6 Cell and Gene Therapy 2.7 Others 3 Cancer Biologics Market Overview by Application 3.1 Global Cancer Biologics Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Cancer Biologics Historic Market Size by Application (2015-2020) 3.3 Global Cancer Biologics Forecasted Market Size by Application (2021-2026) 3.4 Hospitals 3.5 Clinics 3.6 Others 4 Global Cancer Biologics Competition Analysis by Players 4.1 Global Cancer Biologics Market Size by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biologics as of 2019) 4.3 Date of Key Manufacturers Enter into Cancer Biologics Market 4.4 Global Top Players Cancer Biologics Headquarters and Area Served 4.5 Key Players Cancer Biologics Product Solution and Service 4.6 Competitive Status 4.6.1 Cancer Biologics Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Roche 5.1.1 Roche Profile 5.1.2 Roche Main Business 5.1.3 Roche Cancer Biologics Products, Services and Solutions 5.1.4 Roche Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.1.5 Roche Recent Developments 5.2 Novartis 5.2.1 Novartis Profile 5.2.2 Novartis Main Business 5.2.3 Novartis Cancer Biologics Products, Services and Solutions 5.2.4 Novartis Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.2.5 Novartis Recent Developments 5.3 Eli Lilly 5.5.1 Eli Lilly Profile 5.3.2 Eli Lilly Main Business 5.3.3 Eli Lilly Cancer Biologics Products, Services and Solutions 5.3.4 Eli Lilly Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.3.5 Sanofi Recent Developments 5.4 Sanofi 5.4.1 Sanofi Profile 5.4.2 Sanofi Main Business 5.4.3 Sanofi Cancer Biologics Products, Services and Solutions 5.4.4 Sanofi Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.4.5 Sanofi Recent Developments 5.5 Celgene 5.5.1 Celgene Profile 5.5.2 Celgene Main Business 5.5.3 Celgene Cancer Biologics Products, Services and Solutions 5.5.4 Celgene Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.5.5 Celgene Recent Developments 5.6 Pfizer 5.6.1 Pfizer Profile 5.6.2 Pfizer Main Business 5.6.3 Pfizer Cancer Biologics Products, Services and Solutions 5.6.4 Pfizer Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.6.5 Pfizer Recent Developments 5.7 Bayer 5.7.1 Bayer Profile 5.7.2 Bayer Main Business 5.7.3 Bayer Cancer Biologics Products, Services and Solutions 5.7.4 Bayer Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.7.5 Bayer Recent Developments 5.8 Johnson & Johnson 5.8.1 Johnson & Johnson Profile 5.8.2 Johnson & Johnson Main Business 5.8.3 Johnson & Johnson Cancer Biologics Products, Services and Solutions 5.8.4 Johnson & Johnson Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.8.5 Johnson & Johnson Recent Developments 5.9 Bristol-Myers Squibb 5.9.1 Bristol-Myers Squibb Profile 5.9.2 Bristol-Myers Squibb Main Business 5.9.3 Bristol-Myers Squibb Cancer Biologics Products, Services and Solutions 5.9.4 Bristol-Myers Squibb Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.9.5 Bristol-Myers Squibb Recent Developments 5.10 Merck 5.10.1 Merck Profile 5.10.2 Merck Main Business 5.10.3 Merck Cancer Biologics Products, Services and Solutions 5.10.4 Merck Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.10.5 Merck Recent Developments 5.11 Amgen 5.11.1 Amgen Profile 5.11.2 Amgen Main Business 5.11.3 Amgen Cancer Biologics Products, Services and Solutions 5.11.4 Amgen Cancer Biologics Revenue (US$ Million) & (2015-2020) 5.11.5 Amgen Recent Developments 6 North America 6.1 North America Cancer Biologics Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Cancer Biologics Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Cancer Biologics Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Cancer Biologics Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Cancer Biologics Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Cancer Biologics Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Cancer Biologics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Cancer Biologics Market Size by Region (2015-2020) (US$ Million) Table 3. Global Cancer Biologics Market Size Share by Region (2015-2020) Table 4. Global Cancer Biologics Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Cancer Biologics Forecasted Market Size Share by Region (2021-2026) Table 6. Global Cancer Biologics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Cancer Biologics Market Size by Type (2015-2020) (US$ Million) Table 8. Global Cancer Biologics Revenue Market Share by Type (2015-2020) Table 9. Global Cancer Biologics Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Cancer Biologics Revenue Market Share by Type (2021-2026) Table 11. Global Cancer Biologics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Cancer Biologics Market Size by Application (2015-2020) (US$ Million) Table 13. Global Cancer Biologics Revenue Market Share by Application (2015-2020) Table 14. Global Cancer Biologics Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Cancer Biologics Revenue Market Share by Application (2021-2026) Table 16. Global Cancer Biologics Revenue (US$ Million) by Players (2015-2020) Table 17. Global Cancer Biologics Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biologics as of 2019) Table 19. Date of Key Manufacturers Enter into Cancer Biologics Market Table 20. Global Cancer Biologics Top Players Headquarters and Area Served Table 21. Cancer Biologics Product Solution and Service Table 22. Global Cancer Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Roche Basic Information List Table 25. Roche Description and Business Overview Table 26. Roche Cancer Biologics Products, Services and Solutions Table 27. Revenue (Million US$) in Cancer Biologics Business of Roche (2015-2020) Table 28. Roche Recent Developments Table 29. Novartis Basic Information List Table 30. Novartis Description and Business Overview Table 31. Novartis Cancer Biologics Products, Services and Solutions Table 32. Revenue (Million US$) in Cancer Biologics Business of Novartis (2015-2020) Table 33. Novartis Recent Developments Table 34. Eli Lilly Basic Information List Table 35. Eli Lilly Description and Business Overview Table 36. Eli Lilly Cancer Biologics Products, Services and Solutions Table 37. Revenue (Million US$) in Cancer Biologics Business of Eli Lilly (2015-2020) Table 38. Eli Lilly Recent Developments Table 39. Sanofi Basic Information List Table 40. Sanofi Description and Business Overview Table 41. Sanofi Cancer Biologics Products, Services and Solutions Table 42. Revenue (Million US$) in Cancer Biologics Business of Sanofi (2015-2020) Table 43. Sanofi Recent Developments Table 44. Celgene Basic Information List Table 45. Celgene Description and Business Overview Table 46. Celgene Cancer Biologics Products, Services and Solutions Table 47. Revenue (Million US$) in Cancer Biologics Business of Celgene (2015-2020) Table 48. Celgene Recent Developments Table 49. Pfizer Basic Information List Table 50. Pfizer Description and Business Overview Table 51. Pfizer Cancer Biologics Products, Services and Solutions Table 52. Revenue (Million US$) in Cancer Biologics Business of Pfizer (2015-2020) Table 53. Pfizer Recent Developments Table 54. Bayer Basic Information List Table 55. Bayer Description and Business Overview Table 56. Bayer Cancer Biologics Products, Services and Solutions Table 57. Revenue (Million US$) in Cancer Biologics Business of Bayer (2015-2020) Table 58. Bayer Recent Developments Table 59. Johnson & Johnson Basic Information List Table 60. Johnson & Johnson Description and Business Overview Table 61. Johnson & Johnson Cancer Biologics Products, Services and Solutions Table 62. Revenue (Million US$) in Cancer Biologics Business of Johnson & Johnson (2015-2020) Table 63. Johnson & Johnson Recent Developments Table 64. Bristol-Myers Squibb Basic Information List Table 65. Bristol-Myers Squibb Description and Business Overview Table 66. Bristol-Myers Squibb Cancer Biologics Products, Services and Solutions Table 67. Revenue (Million US$) in Cancer Biologics Business of Bristol-Myers Squibb (2015-2020) Table 68. Bristol-Myers Squibb Recent Developments Table 69. Merck Basic Information List Table 70. Merck Description and Business Overview Table 71. Merck Cancer Biologics Products, Services and Solutions Table 72. Revenue (Million US$) in Cancer Biologics Business of Merck (2015-2020) Table 73. Merck Recent Developments Table 74. Amgen Basic Information List Table 75. Amgen Description and Business Overview Table 76. Amgen Cancer Biologics Products, Services and Solutions Table 77. Revenue (Million US$) in Cancer Biologics Business of Amgen (2015-2020) Table 78. Amgen Recent Developments Table 79. North America Cancer Biologics Market Size by Country (2015-2020) & (US$ Million) Table 80. North America Cancer Biologics Market Size Share by Country (2015-2020) Table 81. Europe Cancer Biologics Market Size by Country (2015-2020) & (US$ Million) Table 82. Europe Cancer Biologics Market Size Share by Country (2015-2020) Table 83. Asia-Pacific Cancer Biologics Market Size by Region (2015-2020) & (US$ Million) Table 84. Asia-Pacific Cancer Biologics Market Size Share by Region (2015-2020) (US$ Million) Table 85. Latin America Cancer Biologics Market Size by Country (2015-2020) & (US$ Million) Table 86. Latin America Cancer Biologics Market Size Share by Country (2015-2020) (US$ Million) Table 87. Middle East & Africa Cancer Biologics Market Size by Players (2015-2020) (US$ Million) Table 88. Middle East & Africa Cancer Biologics Market Size Share by Players (2015-2020) (US$ Million) Table 89. Cancer Biologics Market Trends Table 90. Cancer Biologics Market Drivers Table 91. Cancer Biologics Market Challenges Table 92. Cancer Biologics Market Restriants Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Biologics Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Cancer Biologics Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Cancer Biologics Market Share by Regions: 2020 VS 2026 Figure 4. North America Cancer Biologics Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Cancer Biologics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Cancer Biologics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Cancer Biologics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Cancer Biologics Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Cancer Biologics Market Share by Type in 2020 & 2026 Figure 10. Monoclonal Antibodies Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Vaccines Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Cell and Gene Therapy Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Cancer Biologics Market Size Share by Application in 2020 & 2026 Figure 15. Hospitals Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Clinics Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Others Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Cancer Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players Cancer Biologics Market Share in 2019 Figure 20. United States Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Cancer Biologics Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation

Roche Novartis Eli Lilly Sanofi Celgene Pfizer Bayer Johnson & Johnson Bristol-Myers Squibb Merck Amgen